| Authors: |
Daneshmand S; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. Electronic address: daneshma@med.usc.edu., Zaucha R; Department of Clinical Oncology and Radiotherapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland., Catto JWF; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Tran B; Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Master V; Department of Urology, Emory University, Atlanta, GA, USA., Lotan Y; Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA., Pignot G; Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France., Tubaro A; Department of Urology, Sant'Andrea Hospital, Rome, Italy., Shimizu N; Department of Urology, Gunma Prefectural Cancer Center, Gunma, Japan., Vasdev N; Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, East and North Herts NHS Trust, Stevenage, UK; School of Life and Medical Sciences, University of Hertford, Hatfield, UK., Lee EK; Department of Urology, University of Kansas Health System, Kansas City, KS, USA., Procopio G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Galanternik F; Servicio de Oncología Clínica, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina., Crow L; Johnson & Johnson Spring House, PA, USA., Deprince K; Johnson & Johnson, Beerse, Belgium., Naini V; Johnson & Johnson, San Diego, CA, USA., Triantos S; Johnson & Johnson, Raritan, NJ, USA., Baig M; Johnson & Johnson Spring House, PA, USA., Zhu W; Johnson & Johnson, Raritan, NJ, USA., Maranchie JK; Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. |
